0001144204-13-031123.txt : 20130522 0001144204-13-031123.hdr.sgml : 20130522 20130522165239 ACCESSION NUMBER: 0001144204-13-031123 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20130522 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130522 DATE AS OF CHANGE: 20130522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25809 FILM NUMBER: 13865391 BUSINESS ADDRESS: STREET 1: 450 NORTH BRAND BLVD., STREET 2: SUITE 600 CITY: GLENDALE STATE: CA ZIP: 91203 BUSINESS PHONE: 818-507-4617 MAIL ADDRESS: STREET 1: 700 N. BRAND BLVD., STREET 2: SUITE 450 CITY: GLENDALE STATE: CA ZIP: 91203 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 8-K 1 v346017_8k.htm 8-K

 

UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 22, 2013

 

APOLLO MEDICAL HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   000-25809   20-8046599
(State or Other Jurisdiction   (Commission File   (I.R.S. Employer
of Incorporation)   Number)   Identification Number)

 

700 N. Brand Blvd., Suite 450, Glendale, CA 91203

(Address of principal executive offices) (zip code)

 

(818) 396-8050

(Registrant's telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On May 22, 2013, the Board of Directors (“Board”) of Apollo Medical Holdings, Inc. (the “Company”) elected David G. Schmidt, 65, as an independent member of the Board. Mr. Schmidt entered into the Company’s form of Director Agreement, which entitles him to receive a fee of $1,000 per Board meeting attended, as well as a grant of 400,000 restricted shares of the Company’s common stock for his Board service. These restricted shares will vest evenly on a monthly basis over a 3-year period.

 

On May 22, 2013, the Company issued a press release announcing the election of Mr. Schmidt to the Board, which press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

  (d) Exhibits.
   
  The following exhibit is furnished as part of this report.

  

  Exhibit No.   Description
       
  99.1   Press Release dated May 22, 2013 and titled “Apollo Medical Holdings Announces the Appointment of David G. Schmidt to Its Board of Directors”

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

       
  APOLLO MEDICAL HOLDINGS, INC.
       
Date: May 22, 2013 By:   /s/ Warren Hosseinion
  Name:   Warren Hosseinion
  Title:   Chief Executive Officer

 

 
 

 

EXHIBIT INDEX

     
Exhibit No.   Description
   
99.1   Press Release dated May 22, 2013 and titled “Apollo Medical Holdings Announces the Appointment of David G. Schmidt to Its Board of Directors”

  

 

 

EX-99.1 2 v346017_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

 

Apollo Medical Holdings Announces the Appointment of

David G. Schmidt to its Board of Directors

 

GLENDALE, CA − (PR Newswire) – May 22, 2013 − Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB:AMEH), an integrated physician-driven healthcare delivery company that puts ‘Patients First,’ today announced the appointment of David G. Schmidt as an independent member of its Board of Directors.

 

Schmidt is currently a Principal of Schmidt & Associates, a consultancy practice that focuses on strategic planning and implementation in the healthcare industry. From 2002 to 2010, he served as the CEO and Member of the Board of SCAN Health Plan, the tenth largest Medicare Advantage plan in the country. With revenues exceeding $1.8 billion, the Company served more than 130,000 Medicare beneficiaries, including a large number of individuals receiving both Medicare and Medicaid.

 

Prior to joining SCAN, Schmidt served as CEO of Medicheck, a firm that provided Internet-based financial service management to healthcare organizations. He led the Company from development stage through its sale to a healthcare IT company, Passport Health Communications. He then served on Passport’s Board for four years. Prior to Medicheck, Schmidt was the Senior Vice President of Sales and Customer Services for Care America/Blue Shield Health Plan and Regional Vice President for FHP Healthcare. He received a BA in Economics from UCLA and an MBA from The Anderson School of Management at UCLA.

 

“We are honored to have David join our Board of Directors,” stated Warren Hosseinion, MD, Chief Executive Officer of ApolloMed. “His wealth of industry experience in working with the specialized needs of high growth healthcare companies should prove invaluable to us as we persist in executing strategies to nationally distinguish ApolloMed as a noted leader in integrated healthcare delivery.”

 

“I am very pleased to be joining the ApolloMed team, as I believe their physician-driven, patient-centric approach to healthcare delivery will prove to be part of the solution to our country’s healthcare crisis,” added Schmidt.

 

About Apollo Medical Holdings, Inc. (ApolloMed)

Headquartered in Glendale, California and dedicated to putting the ‘Patient First,’ ApolloMed is a physician-driven integrated healthcare delivery company, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern and Central California.  ApolloMed is addressing the healthcare needs of the nation’s largest population center by leveraging its integrated healthcare delivery platform through its complementary physician groups:  ApolloMed Hospitalists and ApolloMed ACO (Accountable Care Organization).  This platform combines hospitalist medicine, critical care medicine, patient care coordination, case management and transition management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements.  ApolloMed strives to improve medical outcomes with high quality, cost efficient care.  For more information, please visit www.apollomed.net.

 

 
 

 

Forward Looking Statements

This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. (“the Company”).  In particular, when used in the preceding discussion, the words “predicts,” "believes," "expects," "intends," “seeks,” “estimates,” "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as “will,” “may,” “might,” “should,” “would” and “could” are intended to identify forward-looking statements.  In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends.  Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results.  The forward-looking statements included herein are made only as of the date hereof.  The Company cannot guarantee future results, levels of activity, performance or achievements.  Accordingly, you should not place undue reliance on these forward-looking statements.  Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended January 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.

 

 

FOR ADDITIONAL INFORMATION

HANOVER|ELITE

Dodi Handy or Kathy Addison

407-585-1080 or via email at AMEH@hanoverelite.com

 

Description: Capture

 

 

 
GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX. M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_ MVP!#`0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P``1"`!V`54#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"DS@9C]X\>PJ>*6L>*3I6UHUDU_ M,/K[5Z$THHY(MR9=@8L,Y`4?Q,<`?C4XU6R@($EY$#Z#FM"?3[:YM? MLTL0,7]WI7(ZSX5-BIGM,O!W7NO_`-:N>')4=I.QK/G@KI7.MMM0M;C`BN(G M/H&Y_*K=>5K"48,A*L.A'!KH]$\1S6SK!?,9(CP'/5:JIAFE>+N3#$7TDCL: M*16#J&4Y!Y!%+7(=(45DZYXGTSP]&&U"X"LWW8UY8_A7-?\`"V=(WX^SW&,_ M>XH`[NBLG0_$VF^(8F;3YP[+]Y#PP_"FZ[XHT[PX8AJ,C)YOW=JYH`V**YA? MB#H3:9)?"Y(C1MF"OS,?0"J-G\4]%N;D12B:W5C@.XR/TH`[6BF1R)-&LD;! MD89#`Y!%9&N^+-+\/`"^N!YI&1&O+'_"@#:HKA4^+.CM(`\%PB_WB`:ZS2=9 MLM;M!YD MMUA,3[<*CV5P;JQM[@C:98URFES6T%[2%[7->BN?N_&6G6T MQC3?,5."4Z5H:7K5IJZ,;9_F7[R'J*'2FES-:`JD&[)FA14-SNQN#6D[K& MA=V"JHR2>U3*+B[-%*2DKH=6)XBUY]$%N4A63S21R<8Q4$_C73HIBB"20`XW M*.*QO%VI6VJ6MC-:R;EW-D=QP*Z*5"7.N=:&%6LN5\KU.@\.Z^^M_:-\*Q^4 M1T.*C4:1=&3E!-A1116)J%%%%`"$X%9VJ1?:]/ MN8!U9#C\.:O3-M2L^28JX8=0:N"UNB9;6.`CD(X.A&TFF/H*A M@01D'@BEHKC.HXK5],%G?,$'[M_F7VJCY%=9KT(DCB;'()K%\BN^G4;BKG+. M"3T-?PW=-):-`YR8NA/I6S6!HB%+X^A0UO\`:N2JO>T-Z?PGA7BFVU75?%-[ M,]G*?B=]@O9;/1 MX(Y'B.UYI/NY[X%7'BSQ+82W%R9S8JN\Y&Q,>WK6993\#7T[\:XSPC_P`C7I__`%T%=G\8/O:=^-`'+^#/"W_"5:C+#+,\ M5M`N]RO4YXXJ+QCX:'AC6!:I(TL,B;T9NN/0UU_P@5=FH-_%D#\*K?%Y1]NL M#CG81F@#;^'.MLW@R8W#;OL)8#)_A`R*\NN)KG7]=9Y&+W%U-@'ZFNL\%R./ M!?B,#A1"2#[X-N^*M7DTGX>6[0-MFFMXXU/IE1G]*\BU?\`Y"E]_P!=G_G7 MH?Q'8CP7H0!X.S/O^[%`')>#?#R^)-=6VF9E@12\K+U_R:T/'_A*W\-7%M)9 MLQM[C(VMSAA5_P"$?_(>O?\`KB/YUM?%Y0='L21R)CC\J`&_";59+C3KO3Y6 M+"W(=,]@>U8]Y_Q^S?[Y_G3_`(1EAJU^`,J8AD^E,N_^/Z;_`*Z'^==V"WD< M>,V1T2^$%.B&[>=OM!3?M_A^EF-_R+?_;#^E>;V7_' M_!_UT'\ZVH5)34N8RK4XQ<;&_J_A)-,T$YFB\0P*IXD! M5OIBNP\6?\B[<_05Q?A?_D8[3ZG^533FYT9.7F.I!0JQ4?(T?&]^\NHI:!OW M<2@D>I-2^'O"UOJ.F?:KIGS)G8%/05E^*23XBNL^P_2I=.BU]K&,V#2BWYV! M3Q3Y6J,5%V%S)U6Y*YFS))I6JL$8^9!)P:[#Q5J)_P"$=AV-@W.,D?3)KG9O M#^LW$K2RV[O(W)8GK6EXKB>#0]*CD&UU)!'IQ1/EE.&MV$>:,9Z6,C0-'_MF M^,+,4C098CK3_$&B_P!BW:(CEXI!E2>M:_@$`W%Z>X5?ZT_Q\!_H)[Y8?RH] MK+V_)T#VJHYD;_`+YK+U#Q@`A6 MRB.3T=_\*YR1JOZ'HSZG1[5IM%D\#`'`'H*!;Y/`KGYSH4>A%IMOLD9\=L5*M/_`.N@KM/C!][3OQI^F_"R\TW4K>[CU2,M"X;'E]1GI4?Q@^]I MWXT`9/PT\06FC:I*M,O!YIAN(6&Q\9!]B*V+7X0W)G475^BP@_-L7DT`7/AWI3W/@K4P1 MC[4710>_%>=6$YTO68)W7FVGR5/L:^A-.T^#2["&SM4V0Q+M45Q_BCX:0:Q> MO>V$XM9GYD0KE6/K[4`3^-/$^G/X-N!;W<4DEW'L14;)Y[UYWX!L7O?&%EL& M5@;S7^@K=7X1Z@64-?1!>YQG%=WX6\(V?A>V80DRW$G^LE8&-.GMI+ MA9S*^[<%QCB@#Q'5_P#D*7W_`%V?^=>H>.[%KKX>6$R+G[/'$Y^A4"J%[\)+ MFZN[B8:FBB5V8#R^F37HD>GQG2(["Y42QB%8G!'#8&*`/'OAOK%OI/B0BZ=8 MXKA-F]N@/:M?XJZW:W[V5E:3)*8B9'*'(&1C%3ZE\(V-RSZ;?!86.1'(O*_C M45G\(KEK@&]OU$0Z[!DGVH`G^$-BZIJ%\P_=OB-3[CK5"[_X_IO^NA_G7I^E MZ5;:/I\=G9)LB08'J3ZFN9F\#32W#R"\4;FW8VUUX6I&#?,SFQ-.4[;V7_`!_P?]=!_.O4#9DZ7]EW<^7LW5S$'@::&XCD-XI",&QM MJL/5A%2NR:].4G&R-GQ9_P`B[<_05Q?A?_D8[3ZG^5=_K&GMJ>F2VJN$+_Q$ M=*P])\'RZ;J<-TUTKB,GY0N,\4J-2,:4HMZCJTY2J*26AB^,K=HM?>1A\LJ` MJ?H,5O>$]6M4T189IDC>#((8XXZYK5UC1H-9MA'-E77[CCJM?VE]3%0J\G)83P#TOOJG\C78UB>' M=`?1/M&^82^:01@8QBMNN.O)2J-HZZ,7&"3"BBBL34****`"FNBR(5=0RGJ# M3J*`,:[\/1RDF"0Q^QY%9S^%KIF_UJ8]:ZJDK6-::,W2BSG[3PE;QL'NI&F( M_A'`K>CB2*,)&H5!P`!3Z*F4Y3^)E1@H["8%&*6BH*"BBB@!*6BB@!*X;XC^ M&]1U]K/^SHA)Y>=V3C%=U24`<3\.?#NH:!%>+J$0C,C`K@YKMZ**`"BBB@`H MHHH`****`"BBB@`HHHH`****`"DI:*`$HI:*`"BBB@!*6BB@!**6B@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` "_]D_ ` end GRAPHIC 4 image_002.jpg GRAPHIC begin 644 image_002.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX. M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_ MVP!#`0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P``1"``]`#@#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:DHK/U2_ M^S*L:$>8_P"@II4D\#/TJW3L M2I7-&BF(Q(Y!IU9EBT444`(:Y+6)RVL3`_P8`KJI&VK7)>(H3%>K<@?)*,$^ MC"M\.O>,JWPES2K9KR0YXC7J?Z5HZAI+7,(%M<20%1PJGY3]:DT6$1:7#@XR>%D']:N:Y9K-`)@/ MGC/7U%87V?VK=.-6.J,K.F]#L0:*J:;,TMBA?EA\I_"BN-JSL="U'7;%<>XK M+NO+FB>*==\;CD=Q[CWK8N(?.B('WATK`N2R.5<88=C6U/4B9JZ=<01VD4/G MABBXRW!JS)>6\2EGFC`'^U7(S/541R7,HCA4NYZ`5I[!/5LCVMM$=0-4CU%I MXK=2T:+RY[GVJ#[/ZBK6FZ6+&S$1Y=CN<^]6Q;@GVK/F47:.Q:3:NQMA'Y=L M!ZDFBK0```'045B]7IJ*`,UM!LF;)1L>F[BK5O9P6JX :@B5/<#FK%%4Y-Z7%RH3'%+114C"BBB@#_]D_ ` end